Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
Journal of Zhejiang University. Science. B|August 8, 2023
Composite B-cell and T-cell lymphomas: clinical, pathological, and molecular features of three cases and literature reviewXueli Jin, Hui Liu, Jing Li, et al.
Frontiers in Immunology|July 20, 2023
Exploration of prognosis and immunometabolism landscapes in ER+ breast cancer based on a novel lipid metabolism-related signatureLesang Shen, Huanhuan Huang, Jiaxin Li, et al.
Heliyon|July 26, 2024
Peripheral inflammatory T cell subsets are effective predictive factors in the development of heterotopic ossification after posttraumatic elbow surgeryZengfeng Xin, Junhua Chen, Fengbo Huang, et al.
Nature Communications|June 16, 2023
Single cell profiling of female breast fibroadenoma reveals distinct epithelial cell compositions and therapeutic targetsZhigang Chen, Yi Zhang, Wenlu Li, et al.
Clinical Breast Cancer|February 17, 2024
Can We Do Breast-Conserving Surgery Without Intraoperative Frozen Section of Margin?Dongyan Xu, Kaiyue Wang, Chen Lin, et al.
Frontiers in Oncology|October 9, 2025
Case Report: Metastasis to pleura and mediastinal lymph nodes from breast secretory carcinoma: 10 years follow-upFengbo Huang, Jing Zhao, Jie Lian, et al.
Nucleic Acids Research|November 11, 2025
PersADE: a database of personalized adverse drug events and their underlying molecular mechanismsZhuohang Yu, Yimeng Wang, Yintao Zhang, et al.
NPJ Precision Oncology|December 23, 2024
AI-driven eyelid tumor classification in ocular oncology using proteomic dataLinyan Wang, Xizhe Dai, Zicheng Liu, et al.
Communications Biology|May 5, 2026
Senescent endothelial cell-derived extracellular vesicles promote neoadjuvant chemoresistance in colorectal cancer via GPX4Kunpeng Jia, Yuxin Ding, Menglei Jin, et al.
Medcomm|October 13, 2025
Efficacy, Safety, and Biomarkers of Neoadjuvant Dalpiciclib (CDK4/6 inhibitor) plus Aromatase Inhibitors in Operable HER2-Negative Luminal B Breast Cancer: A Prospective, Single-Center, Single-Arm, Phase II Trial (DANCER)Yunxiang Zhou, Zhiyun Zhang, Huihui Chen, et al.
Pageof 3